drug

BNT165C

1 story · latest Aug 28, 2026

Status: Investigational
Trials: 1 registered trial in coverage

Relationships

Developed by BioNTech SE

Timeline

BioNTech posts results for Phase I/IIa malaria RNA vaccine trial; CHMI portion skipped

Aug 28Trial updateBioNTech SE BNT165C

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.